Ono Pharmaceutical Co Ltd (OPHLY)
4.43
-0.10
(-2.21%)
USD |
OTCM |
Sep 27, 15:59
Ono Pharmaceutical Total Liabilities (Quarterly): 760.22M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 760.22M |
December 31, 2023 | 716.51M |
September 30, 2023 | 753.95M |
June 30, 2023 | 714.29M |
March 31, 2023 | 1.010B |
December 31, 2022 | 787.36M |
September 30, 2022 | 655.04M |
June 30, 2022 | 633.16M |
March 31, 2022 | 635.20M |
December 31, 2021 | 640.74M |
September 30, 2021 | 832.57M |
June 30, 2021 | 838.92M |
March 31, 2021 | 958.03M |
December 31, 2020 | 880.46M |
September 30, 2020 | 910.31M |
June 30, 2020 | 832.49M |
March 31, 2020 | 975.47M |
December 31, 2019 | 791.53M |
September 30, 2019 | 807.52M |
June 30, 2019 | 800.34M |
March 31, 2019 | 832.63M |
December 31, 2018 | 725.60M |
September 30, 2018 | 617.07M |
June 30, 2018 | 650.64M |
March 31, 2018 | 749.11M |
Date | Value |
---|---|
December 31, 2017 | 607.22M |
September 30, 2017 | 616.25M |
June 30, 2017 | 599.04M |
March 31, 2017 | 834.03M |
December 31, 2016 | 636.79M |
September 30, 2016 | 663.92M |
June 30, 2016 | 609.05M |
March 31, 2016 | 571.14M |
December 31, 2015 | 398.83M |
September 30, 2015 | 389.23M |
June 30, 2015 | 405.76M |
March 31, 2015 | 411.34M |
December 31, 2014 | 349.51M |
September 30, 2014 | 285.62M |
June 30, 2014 | 379.35M |
March 31, 2014 | 334.43M |
December 31, 2013 | 369.31M |
September 30, 2013 | 328.91M |
June 30, 2013 | 343.53M |
March 31, 2013 | 345.44M |
December 31, 2012 | 331.43M |
September 30, 2012 | 371.33M |
June 30, 2012 | 448.31M |
March 31, 2012 | 439.19M |
December 31, 2011 | 390.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
633.16M
Minimum
Jun 2022
1.010B
Maximum
Mar 2023
796.53M
Average
791.53M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 52.37B |
Nxera Pharma Co Ltd | 543.75M |
PeptiDream Inc | 230.61M |
Healios KK | 90.39M |
AnGes Inc | 13.66M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.037B |
Shareholders Equity (Quarterly) | 5.239B |
Current Ratio | 3.991 |